Guidelines for clinical translation and commercialization of extracellular vesicles and exosomes based therapeutics is a research paper published in Extracellular Vesicle (2023). On theSindex it has a DataRank of 0.795. It has been cited 200 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.795
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →American Heart Association
Grant: 19EIA34660286
University of Texas MD Anderson Cancer Center
Grant: CA231465
University of Texas MD Anderson Cancer Center
Grant: R35CA263815
National Institutes of Health
Grant: HL147357
National Institutes of Health
Grant: HL137093
National Institutes of Health
Grant: HL146153
National Institutes of Health
Grant: HL144002
National Institutes of Health
Grant: HL149940
National Institutes of Health
Grant: HL123920
FWCI
19.04
Citation Percentile
1.0%
Influential Citations
5
Citation Trend
Fields of Study
Keywords
Additional file 1 of Cell-specific extracellular vesicle-encapsulated exogenous GABA controls seizures in epilepsy
Additional file 1 of Cell-specific extracellular vesicle-encapsulated exogenous GABA controls seizures in epilepsy